New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma.
Saito T, Kanao K, Matsumoto K, Fukumoto K, Igarashi D, Takahashi T, Kaneko G, Shirotake S, Nishimoto K, Mizuno R, Ishida M, Hara S, Oya M, Oyama M.
Saito T, et al. Among authors: fukumoto k.
BJUI Compass. 2023 Oct 27;5(2):281-288. doi: 10.1002/bco2.298. eCollection 2024 Mar.
BJUI Compass. 2023.
PMID: 38371203
Free PMC article.